Status

Current status by peptide

FDA Approved Approved by the FDA for at least one named indication and sold in the United States under an approved label.

Gonadorelin Gonadorelin (GnRH) HCG Human Chorionic Gonadotropin Melanotan I Melanotan I (Afamelanotide) Oxytocin Pentosan Polysulfate Pentosan Polysulfate Sodium PT-141 Bremelanotide Semaglutide Sermorelin Sermorelin (GRF 1-29) Tesamorelin Tirzepatide Tirzepatide (LY3298176)

Approved Abroad Approved by another country's health authority, not the FDA. Each entry notes where it is a registered drug.

GHRP-2 Growth Hormone Releasing Peptide-2 Approved diagnostic agent in Japan Selank Selank (TP-7) Approved in Russia and Ukraine Semax Approved in Russia and Ukraine Thymosin Alpha-1 Approved pharmaceutical in 35+ countries

Research FDA research stage. Studied in the literature, with no approval for human use from the FDA or another health authority.

5-Amino-1MQ 5-Amino-1-Methylquinolinium AOD-9604 AOD-9604 (HGH Fragment 176-191) BPC-157 Body Protection Compound 157 CJC-1295 CJC-1295 (with/without DAC) Dihexa Dihexa (PNB-0408) DSIP Delta Sleep-Inducing Peptide Epithalon Epithalamin / Epitalon GLP-1 Glucagon-Like Peptide-1 (native hormone) Humanin Humanin (HN) Ibutamoren Ibutamoren (MK-677) IGF-1 LR3 IGF-1 LR3 (Long Arg3-IGF-1) Ipamorelin Kisspeptin-10 KPV KPV (Lysine-Proline-Valine) LL-37 LL-37 (Cathelicidin Antimicrobial Peptide) Melanotan II MGF Mechano Growth Factor (IGF-1Ec) MOTS-c Mitochondrial ORF of 12S rRNA-c NAD+ Nicotinamide Adenine Dinucleotide Pinealon SLU-PP-332 TB-500 Thymosin Beta-4 Fragment

Cosmetic / Research Approved for non-drug use only, such as a cosmetic ingredient. Any drug use is still at the research stage.

GHK-Cu Copper Peptide GHK-Cu

Clinical Trials In the FDA pipeline, testing effectiveness and dosing in human trials. Not approved.

Cagrilintide Retatrutide Retatrutide (LY3437943) SS-31 Elamipretide (MTP-131)

Preclinical Lab and animal studies only. No human trial data, and no approval from any health authority.

Follistatin-344 Follistatin-344 (FST-344) FOXO4-DRI FOXO4-D-Retro-Inverso Peptide PEG-MGF Pegylated Mechano Growth Factor

Research Phase FDA research stage. No approval for human use from the FDA or another health authority.

ARA-290 ARA-290 (Cibinetide) GHRP-6 Growth Hormone Releasing Peptide-6 Hexarelin Hexarelin (Examorelin) Mazdutide Mazdutide (IBI362) N-Acetyl Semax N-Acetyl Semax Amidate Survodutide Survodutide (BI 456906) Thymalin Thymalin (Thymic Polypeptide Complex) Thymogen Thymogen (Glu-Trp Dipeptide) VIP Vasoactive Intestinal Peptide

⚠️ Each group records a compound's furthest documented regulatory milestone across three separate tracks: the FDA's clinical trial and approval pipeline, approval by another country's health authority (Russia and Ukraine's Ministry of Health, for instance, or the 35 or more countries where Thymosin Alpha-1 is approved), and non-drug regulatory approval such as cosmetic-ingredient status. These tracks are independent. A compound approved by another country, or approved for non-drug use, has not been evaluated or approved by the FDA for drug use in the United States.

Open any compound for its full profile, including sourced research and legal status.